
Venus Remedies Q2 FY27 Results: Consolidated Net Profit ₹25.65 Crore on Total Income of ₹219 Crore
Venus Remedies (NSE: VENUSREM) reported consolidated total income of ₹219.27 crore and net profit of ₹25.65 crore for the quarter ended 30 Sep 2026, it said in a filing on 26 Oct 2026. Standalone total income was ₹219.16 crore and standalone net profit ₹28.96 crore.
- Earnings
- Pharmaceuticals